Dr. Reddy's Laboratories
Dr. Reddy's Laboratories is a pharmaceutical company operating across four main segments: Generics (branded, unbranded, and biosimilars), API & Services (development, manufacturing, and research support), Innovative Medicines, and Consumer Health solutions. The company manufactures complex APIs and 1,629 drug master files across key therapeutic areas including Oncology, Cardiovascular, and Anti-Diabetes from 23 global manufacturing facilities across 5 countries. Dr. Reddy's operates under cGMP standards with API capabilities based in 8 units audited by regulatory bodies including the US FDA.
Certifications & registrations
Medicines & products
Product list is informational, aggregated from public sources — availability is confirmed per-deal through verified offers, not public listings.
Documents & downloads
Capabilities
Export markets
Facilities
Facility & product gallery
Sourcing from Dr. Reddy's Laboratories through PharmaGlobal
Product, quantity, destination, and documents — in any of 23 languages.
Every requirement passes a first-look review before any supplier exposure.
Price, lead time, documents, and risk — side by side in a private deal room.
Data sources: Company disclosures. Last updated June 11, 2026. Profile data is aggregated from public regulatory registries and company disclosures. PharmaGlobal provides sourcing workflow tools; participants remain responsible for their own regulatory and trade compliance. Inaccurate? Report a correction.
